lomustine has been researched along with amphotericin b in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (68.42) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bortin, MM; Rimm, AA; Rodey, GE; Rose, WC; Saltzstein, EC; Truitt, RL | 1 |
| Marcus, SG | 1 |
| Muller, PJ; Tator, CH | 1 |
| Atassi, G; Hildebrand, J; Laurent, G | 1 |
| Drewinko, B; Gottlieb, JA; Loo, TL | 1 |
| Brajtburg, J; Elberg, S; Medoff, G; Schechtman, KB | 1 |
| Brajtburg, J; Elberg, S; Kobayashi, GS; Medoff, G | 1 |
| Chabot, G; Dieckman, J; Valeriote, F | 1 |
| Brajtburg, J; Medoff, G; Vertut-Croquin, A | 1 |
| Bertrand, M; Bouzaglou, A; Farbstein, M; Gala, K; Green, L; Kennedy, P; Multhauf, P; Presant, CA; Smith, JD; Wiseman, C | 1 |
| Bertrand, M; Chang, FF; Kendregan, B; Klein, L; Mackie, A; Metter, GE; Multhauf, P; Presant, CA; Rappaport, D | 1 |
| Dieckman, J; Flentje, D; Flentje, M; Medoff, G; Valeriote, F | 1 |
| Dieckman, J; Medoff, G; Tolen, S; Valeriote, F | 1 |
| Dewerie-Vanhouche, J; Hildebrand, J; Laurent, G; Machin, D | 1 |
| Choi, JD; Friedman, AH; Powers, CJ; Sampson, JH; Vredenburgh, JJ | 1 |
1 review(s) available for lomustine and amphotericin b
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for lomustine and amphotericin b
| Article | Year |
|---|---|
Effects of amphotericin B with combination chemotherapy on response rates and on survival in non-small cell carcinoma of the lung.
Topics: Altretamine; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Doxorubicin; Drug Evaluation; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Palliative Care; Random Allocation; Time Factors | 1984 |
17 other study(ies) available for lomustine and amphotericin b
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Graft versus leukemia. VI. Adoptive immunotherapy in combination with chemoradiotherapy for spontaneous leukemia-lymphoma in AKR mice.
Topics: Amphotericin B; Animals; Antibodies, Neoplasm; Cyclophosphamide; Graft vs Host Reaction; Immunization, Passive; Leukemia, Experimental; Lomustine; Mice; Mice, Inbred AKR | 1975 |
Amphotericin B and CCNU.
Topics: Amphotericin B; Animals; Blood-Brain Barrier; Lomustine; Mice; Neoplasms, Experimental | 1979 |
The effect of amphotericin B on the survival of brain-tumor-bearing mice treated with CCNU.
Topics: Amphotericin B; Animals; Brain Neoplasms; Drug Synergism; Female; Lomustine; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Nitrosourea Compounds; Transplantation, Homologous | 1978 |
Potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by amphotericin B in murine ependymoblastoma.
Topics: Amphotericin B; Animals; Cell Division; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Synergism; Ependymoma; In Vitro Techniques; Lomustine; Male; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Nitrosourea Compounds; Thymidine; Time Factors | 1976 |
A comparison of the lethal effects of three nitrosourea derivatives on cultured human lymphoma cells.
Topics: Amphotericin B; Carmustine; Cell Line; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Lomustine; Lymphoma; Neoplasms, Experimental; Nitrosourea Compounds; Semustine; Time Factors; Vitamin A | 1976 |
Lysis of human promyelocytic HL-60 cells by amphotericin B in combination with 2-chloroethyl-1-nitrosoureas: role of the carbamoylating activity of nitrosoureas.
Topics: Amphotericin B; Carmustine; Cell Line; Drug Therapy, Combination; Glutathione; Humans; L-Lactate Dehydrogenase; Leukemia, Promyelocytic, Acute; Lomustine; Nitrosourea Compounds | 1990 |
Interference with effects of amphotericin B on Candida albicans cells by 2-chloroethyl-1-nitrosoureas.
Topics: Amphotericin B; Candida albicans; Carmustine; Catalase; Cyanates; Drug Interactions; Lomustine | 1988 |
Schedule-dependent potentiation of lomustine cytotoxicity by amphotericin B in mice.
Topics: Amphotericin B; Animals; Cell Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Female; Kinetics; Leukemia, Experimental; Lomustine; Membrane Fluidity; Mice; Mice, Inbred AKR | 1986 |
Two mechanisms of synergism when amphotericin B is used in combination with actinomycin D or 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea against the human promyelocytic leukemia cell line HL-60.
Topics: Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Cell Count; Cell Line; Dactinomycin; Drug Synergism; Humans; L-Lactate Dehydrogenase; Leukemia, Myeloid, Acute; Lomustine; Malondialdehyde; Oxidation-Reduction; Potassium; Thymidine | 1986 |
Pilot phase II trial of amphotericin B and CCNU in renal and colorectal carcinomas.
Topics: Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Colonic Neoplasms; Drug Evaluation; Humans; Kidney Neoplasms; Lomustine; Pilot Projects; Rectal Neoplasms | 1986 |
Potentiation by amphotericin B of the cytotoxicity of anticancer agents against MOPC-315 plasmacytoma and Lewis lung carcinoma.
Topics: Amphotericin B; Animals; Antineoplastic Agents; Drug Synergism; Drug Therapy, Combination; Female; Lomustine; Lung Neoplasms; Male; Mice; Mice, Inbred Strains; Plasmacytoma | 1984 |
Amphotericin B potentiation of the cytotoxicity of anticancer agents against both normal hematopoietic and leukemia cells in mice.
Topics: Amphotericin B; Animals; Antineoplastic Agents; Cell Survival; Doxorubicin; Drug Synergism; Hematopoietic Stem Cells; Leukemia L1210; Leukemia, Experimental; Lomustine; Melphalan; Mice; Mice, Inbred AKR; Mice, Inbred Strains | 1984 |
Inhibition of RNA synthesis in murine ependymoblastoma by the combination of amphotericin B and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
Topics: Amphotericin B; Animals; Biological Transport; Drug Synergism; Ependymoma; Lomustine; Mice; Neoplasm Proteins; Neoplasms, Experimental; Nitrosourea Compounds; RNA, Neoplasm | 1980 |
Cryptococcal meningitis in patients with glioma: a report of two cases.
Topics: Adult; Aged; Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cerebrospinal Fluid; Cryptococcus neoformans; Dacarbazine; Dexamethasone; Fatal Outcome; Fluconazole; Flucytosine; Glioma; Humans; Immunosuppression Therapy; Lomustine; Male; Meningitis, Cryptococcal; Opportunistic Infections; Temozolomide; Treatment Outcome | 2008 |